Jiang Yanwen,Yuan Qing , Fang Qiuhong*. Schedule-dependent synergistic interaction between docetaxel and gefitinib in NSCLC cell lines and its molecular mechanisms.J Cancer Res Clin Oncol.2014; 140:1087–1095.
Jiang Yanwen, Li Chunsun, Ma Yinmin,Chen Jie, Chen Liangan*.The inhibition of the pemetrexed-activated MAPK pathway via sorafenib is involved in the synergistic mechanism of sorafenib subsequent potentiation of pemetrexed cytotoxicity in EGFR TKI-resistant cell lines. Clin Lab. 2012; 58(5-6):551-61.
Jiang Yanwen, Chen Liangan*. microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer. Mol Med Rep. 2012;5(4):890-4.